The natural history of chronic obstructive pulmonary disease
…, SFP Man, S Van Eeden, DW Mapel… - European …, 2006 - Eur Respiratory Soc
⇓ Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
in the USA, and it remains one of the few diseases that continues to increase its numbers. …
in the USA, and it remains one of the few diseases that continues to increase its numbers. …
COPD as a lung disease with systemic consequences–clinical impact, mechanisms, and potential for early intervention
…, S Rennard, T Troosters, DW Mapel… - COPD: Journal of …, 2008 - Taylor & Francis
The natural course of chronic obstructive pulmonary disease (COPD) is complicated by the
development of systemic consequences and co-morbidities. These may be major features in …
development of systemic consequences and co-morbidities. These may be major features in …
Cardiovascular comorbidity in COPD: systematic literature review
… Dr Mapel: contributed to review of the study proposal and the interim results and writing the
… Dr Mapel has received research grants from and served as an advisor to GlaxoSmithKline plc…
… Dr Mapel has received research grants from and served as an advisor to GlaxoSmithKline plc…
American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
…, JP Lynch, DW Mapel… - … of respiratory and …, 2002 - mayoclinic.elsevierpure.com
Despite the considerable progress in the classification of the idiopathic interstitial pneumonias
(IIPs), the lack of an international standard has resulted in variable and confusing …
(IIPs), the lack of an international standard has resulted in variable and confusing …
Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization
DW Mapel, JS Hurley, FJ Frost… - Archives of internal …, 2000 - jamanetwork.com
Background Information about health care utilization and costs among patients with chronic
obstructive pulmonary disease (COPD) is needed to improve care and for appropriate …
obstructive pulmonary disease (COPD) is needed to improve care and for appropriate …
Burden of concomitant asthma and COPD in a Medicaid population
…, MO Akazawa, CM Blanchette, J Wang, DW Mapel… - Chest, 2008 - Elsevier
Background Asthma and COPD can significantly affect patients and pose a substantial
economic burden for both patients and managed-care plans. This study compares utilization …
economic burden for both patients and managed-care plans. This study compares utilization …
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991–1999
DW Mapel, D Dedrick, K Davis - COPD: Journal of Chronic …, 2005 - Taylor & Francis
Persons with Chronic Obstructive Pulmonary Disease (COPD) are at risk for developing
other smoking-related complications, including cardiac and vascular diseases. Information …
other smoking-related complications, including cardiac and vascular diseases. Information …
[HTML][HTML] The epidemiology and treatment of anal fissures in a population-based cohort
DW Mapel, M Schum, A Von Worley - BMC gastroenterology, 2014 - Springer
Background Anal fissure (AF) is regarded as a common problem, but there are no published
epidemiologic data, nor information on current treatment. The purpose of this study was to …
epidemiologic data, nor information on current treatment. The purpose of this study was to …
Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients
…, R Paulose-Ram, JP Marton, DW Mapel - … journal of chronic …, 2012 - Taylor & Francis
Background We investigated a large population of patients with chronic obstructive
pulmonary disease (COPD) to determine their frequency of medication use and patterns of …
pulmonary disease (COPD) to determine their frequency of medication use and patterns of …
[HTML][HTML] Corticosteroids and the treatment of idiopathic pulmonary fibrosis: past, present, and future
DW Mapel, JM Samet, DB Coultas - Chest, 1996 - Elsevier
Why are corticosteroids used in patients with IPF? There is evidence that corticosteroid
therapy is associated with clinical improvement in only a small percentage of IPF patients. This …
therapy is associated with clinical improvement in only a small percentage of IPF patients. This …